The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure
- PMID: 24485712
- DOI: 10.1016/j.healun.2013.12.005
The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure
Abstract
Background: The acute decompensated heart failure/N-terminal pro-B-type natriuretic peptide (ADHF/NT-proBNP) score is a validated risk scoring system that predicts mortality in hospitalized heart failure patients with a wide range of left ventricular ejection fractions (LVEFs). We sought to assess discrimination and calibration of the score when applied to patients with advanced decompensated heart failure (AHF).
Methods: We studied 445 patients hospitalized for AHF, defined by the presence of severe symptoms of worsening HF at admission, severely depressed LVEF, and the need for intravenous diuretic and/or inotropic drugs. The primary outcome was cumulative (in-hospital and post-discharge) mortality and post-discharge 1-year mortality. Separate analyses were performed for patients aged ≤ 70 years. A Seattle Heart Failure Score (SHFS) was calculated for each patient discharged alive.
Results: During follow-up, 144 patients (32.4%) died, and 69 (15.5%) underwent heart transplantation (HT) or ventricular assist device (VAD) implantation. After accounting for the competing events (VAD/HT), the ADHF/NT-proBNP score's C-statistic for cumulative mortality was 0.738 in the overall cohort and 0.771 in patients aged ≤ 70 years. The C-statistic for post-discharge mortality was 0.741 and 0.751, respectively. Adding prior (≤6 months) hospitalizations for HF to the score increased the C-statistic for post-discharge mortality to 0.759 in the overall cohort and to 0.774 in patients aged ≤ 70 years. Predicted and observed mortality rates by quartiles of score were highly correlated. The SHFS demonstrated adequate discrimination but underestimated the risk. The ADHF/NT-proBNP risk calculator is available at http://www.fsm.it/fsm/file/NTproBNPscore.zip.
Conclusions: Our data suggest that the ADHF/NT-proBNP score may efficiently predict mortality in patients hospitalized with AHF.
Keywords: ADHF/NT-proBNP score; Seattle Heart Failure Model score; advanced decompensated heart failure; risk stratification.
Copyright © 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.Circ J. 2015;79(5):1076-83. doi: 10.1253/circj.CJ-14-1219. Epub 2015 Mar 3. Circ J. 2015. PMID: 25753469 Clinical Trial.
-
Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.Int J Cardiol. 2013 Oct 3;168(3):2120-6. doi: 10.1016/j.ijcard.2013.01.005. Epub 2013 Feb 6. Int J Cardiol. 2013. PMID: 23395457
-
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31. Heart. 2014. PMID: 24179162
-
Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.Am J Cardiol. 2011 Feb 15;107(4):573-8. doi: 10.1016/j.amjcard.2010.10.015. Am J Cardiol. 2011. PMID: 21295174 Review.
-
The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.Minerva Cardioangiol. 2016 Apr;64(2):157-64. Epub 2015 Sep 15. Minerva Cardioangiol. 2016. PMID: 26373781 Review.
Cited by
-
Novel and established biomarkers to complement risk scores in patients with acute decompensated heart failure - a pilot study.Am Heart J Plus. 2025 Apr 10;53:100544. doi: 10.1016/j.ahjo.2025.100544. eCollection 2025 May. Am Heart J Plus. 2025. PMID: 40271152 Free PMC article.
-
Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study.BMC Geriatr. 2017 Jan 26;17(1):34. doi: 10.1186/s12877-017-0419-2. BMC Geriatr. 2017. PMID: 28125958 Free PMC article.
-
The Surprise Question Can Be Used to Identify Heart Failure Patients in the Emergency Department Who Would Benefit From Palliative Care.J Pain Symptom Manage. 2019 May;57(5):944-951. doi: 10.1016/j.jpainsymman.2019.02.007. Epub 2019 Feb 16. J Pain Symptom Manage. 2019. PMID: 30776539 Free PMC article.
-
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure.J Clin Med. 2022 Dec 18;11(24):7503. doi: 10.3390/jcm11247503. J Clin Med. 2022. PMID: 36556120 Free PMC article. Review.
-
Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.Heart Vessels. 2016 May;31(5):722-33. doi: 10.1007/s00380-015-0654-4. Epub 2015 Mar 4. Heart Vessels. 2016. PMID: 25735775
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous